<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005705</url>
  </required_header>
  <id_info>
    <org_study_id>HIC 1307012373</org_study_id>
    <nct_id>NCT02005705</nct_id>
  </id_info>
  <brief_title>Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.</brief_title>
  <official_title>Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients presenting to the emergency room with upper gastrointestinal bleeding and a Glasgow&#xD;
      Blatchford score of zero will be randomly assigned to further care in the inpatient vs.&#xD;
      outpatient setting. The hypothesis of this study is that patients who are managed as&#xD;
      outpatients will require interventions at a rate not higher than those managed as inpatients&#xD;
      and will have lower direct healthcare costs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inadequate recruitment&#xD;
  </why_stopped>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of patients requiring intervention for UGIB (endoscopic therapy, blood transfusion, surgery, interventional radiology)</measure>
    <time_frame>Within 7 days of the index presentation to the emergency room</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Upper Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>Outpatient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Inpatient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outpatient Management of Low-risk Patients</intervention_name>
    <description>Labs will be obtained within 2-3 days of discharge from ED&#xD;
Clinic visit will be scheduled within 3 days of discharge from ED&#xD;
EGD will be scheduled within 7 days of discharge from ED&#xD;
Phone follow-up at day 7 and 30</description>
    <arm_group_label>Outpatient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inpatient Management of Low-risk Patients</intervention_name>
    <description>Labs will be obtained on day of discharge or day 2-3&#xD;
EGD will be performed in the hospital&#xD;
Phone follow-up at day 7 and 30</description>
    <arm_group_label>Inpatient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Blood Urea Nitrogen &lt; 18.2 mg/dl&#xD;
&#xD;
          2. Hemoglobin ≥ 13.0 g/dl for men and ≥ 12.0 g/dl for women&#xD;
&#xD;
          3. Systolic blood pressure ≥ 110 mm Hg&#xD;
&#xD;
          4. Heart rate &lt; 100 beats/min&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to obtain informed consent&#xD;
&#xD;
          2. Pregnancy&#xD;
&#xD;
          3. History of liver disease&#xD;
&#xD;
          4. History of heart failure&#xD;
&#xD;
          5. Syncope that is temporally related to ongoing bleeding&#xD;
&#xD;
          6. Melena&#xD;
&#xD;
          7. Contraindication to proton pump inhibitor use&#xD;
&#xD;
          8. Other conditions that necessitate inpatient evaluation.&#xD;
&#xD;
          9. Inpatients with new onset of GI bleeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loren Laine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University, Section of Digestive Disease</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>December 3, 2013</study_first_submitted>
  <study_first_submitted_qc>December 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2013</study_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Loren Laine</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

